[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neoplasm-of-breast\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neoplasm-of-breast":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100423455","therapeutic-education-and-nursing-support-program-for-supportive-care-in-patients-treated-with-hormone-therapy-for-non-metastatic-breast-cancer-100423455",false,"NCT04794075","Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer","Programme d'Éducation Thérapeutique et d'Accompagnement Infirmier Vers Les Soins de Support, Chez Les Patientes Sous Hormonothérapie Pour un Cancer du Sein Non métastatique","ETAPH","Inclusion Criteria:\n\n* Female patients aged 18 to 75 years inclusive\n* Patients with non-metastatic breast cancer for whom adjuvant hormone therapy (anti-oestrogen or anti-aromatase) is indicated, depending on the decision of the multidisciplinary consultation meeting.\n* Performance status (ECOG) ≤ 2\n* Patient able to read and understand French (common use)\n* Patient with access to an internet connection (for collection of adverse events and responses to questionnaires on the electronic platform)\n* Patient who has been informed and has given written consent to participate in the study\n* Patient affiliated to the French social security system or equivalent\n\nExclusion Criteria:\n\n* Patient with metastatic cancer (stage IV)\n* Patient undergoing neoadjuvant hormone therapy\n* Patient who started hormone therapy prior to inclusion in the study\n* Patient with a history of other cancer treated by radiotherapy, chemotherapy or hormone therapy, with an end of treatment less than 2 years ago.\n* For patients in the experimental group: Inability of the patient to travel to the hospital to attend the initial assessment day and the proposed group outpatient workshops; follow-up of the program difficult for geographical, physical or other reasons (at the discretion of the investigator).\n* For patients in the control group: patients for whom telephone nursing follow-up is planned for 2 months or more or more than 4 sessions of therapeutic education.\n* Pregnant and breastfeeding women\n* Patient with a documented history of cognitive or psychiatric disorders\n* Refusal to participate, protected adult patient, under guardianship or curatorship","FEMALE","18 Years","75 Years",{"count":21,"type":22},300,"ESTIMATED","INTERVENTIONAL",[25],"NA","To compare the efficacy of the addition of a therapeutic education program combined with nursing phone follow-up, compared to conventional management alone, on the management of adverse events (AEs) related to adjuvant hormone therapy during the first year of treatment in patients with non-metastatic breast cancer.",[28],"Neoplasm of Breast",[30,31,32,33,34],"Therapeutic Education","Nursing Support Program","Hormone Therapy","Non-metastatic Breast Cancer","Breast Cancer","RECRUITING","2025-07-30",{"date":38,"type":39},"2025-08-03","ACTUAL",{"date":41,"type":39},"2021-08-09",{"date":43,"type":22},"2027-08",{"name":45,"class":46},"Centre Hospitalier Emile Roux","OTHER",9]